January 04, Colombo (LNW): Sri Lanka’s State Pharmaceuticals Manufacturing Corporation (SPMC) has announced plans to roll out ten new medicines this year, signalling a further expansion of its domestic production capacity and product range.
In a statement, the state-owned manufacturer said it is aiming to produce around four billion tablets and capsules over the course of the year, building on steady growth achieved in recent times. At present, the corporation manufactures about 70 different pharmaceutical items that are supplied mainly to the public health sector.
Last year marked a record-breaking period for the SPMC, with output reaching an all-time high of more than 3.6 billion tablets and capsules. The corporation also reported its strongest monthly performance in March, when production peaked at approximately 385 million units.
During 2025, five new pharmaceutical products were added to the local market, while the corporation maintained an uninterrupted supply of medicines to meet all requirements issued by the Medical Supplies Division, despite ongoing challenges faced by the health sector.
Financially, the SPMC closed 2025 on a strong note, generating revenue of over Rs. 27 billion.
